Nothing new here, just a repeat of previous presentations point...

  1. 175 Posts.
    lightbulb Created with Sketch. 14
    Nothing new here, just a repeat of previous presentations point for point. Gary should just voiceover his PowerPoint presentation and email it in. Lots of short term speculation conspicuous in the share price.
    IMO 3 options going into next year
    SNT partners for 1 indication ( Parkinson's, Scarring or Myleo )
    SNT partners with company ABC after some or all phase 2 results, shareholder dilutive as with ARIX previously
    SNT receives no direct funding / partnership & has to undertake another dilutive capital raising to move to Phase 3 for some of these drug candidates
    Speculative is a good description when you consider funding past June 2025
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.1¢
Change
0.004(8.51%)
Mkt cap ! $82.87M
Open High Low Value Volume
4.8¢ 5.4¢ 4.7¢ $857.5K 17.69M

Buyers (Bids)

No. Vol. Price($)
2 69701 5.0¢
 

Sellers (Offers)

Price($) Vol. No.
5.2¢ 70931 3
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.